For 39-year-old Chioma Ifeanyi, tuberculosis (TB) was more than just a debilitating lung disease; it was a brutal test of resilience against deep-seated societal stigma. “When people hear tuberculosis, they immediately think you are contagious forever. Some neighbours stopped visiting me when they heard about my diagnosis,” Chioma recounted, her words echoing the painful reality many TB patients endure in Nigeria.
A mother of three living in Kubwa, Abuja, Chioma's ordeal began last April with persistent fatigue and fever, symptoms she initially dismissed as malaria. “I treated malaria three times, but nothing changed. I kept losing weight and sweating at night. Eventually, a doctor advised me to do a TB test,” she explained. The diagnosis was a shock. “The first thing I thought was: ‘Will people avoid me?’”
Despite free treatment at a public hospital, Chioma found the emotional toll of stigma as challenging as the physical symptoms. “My family encouraged me to continue the drugs even when I felt weak. Without them, I might have given up,” she confessed.
The Shadow of Stigma: Personal Battles Against a Public Health Crisis
Chioma's story is far from isolated. For student Ezeh Daniella, the fear of judgment initially prevented her from seeking help. “I kept telling myself it was just stress. But I became extremely thin and weak,” she recalled. It took a friend’s gentle persuasion to get her to a clinic. “At first, I felt ashamed. I worried about what my classmates would think.” Daniella, now recovered, courageously shares her experience to advocate for early diagnosis, highlighting a common, yet often overlooked, dimension of Nigeria’s TB challenge: social isolation.
As World TB Day was marked globally, survivors, medical professionals, and public health advocates united in their call for heightened awareness, early detection, and sustained support systems to combat both the disease and its pervasive stigma.
Twenty-eight-year-old Bello Tijani, residing in Bmuko, Abuja, can attest to the sheer physical demand of TB treatment. For nearly three months, his mornings began before dawn, swallowing a handful of bitter pills that induced nausea and weakness. He understood the stakes: missing a single dose could mean restarting the arduous regimen.
Faruk Nako, a 35-year-old commercial driver, nearly succumbed to the side effects. “The drugs made me dizzy, and I could barely eat. At one point, I told myself, ‘Maybe I should just stop,’” he admitted. His doctor’s warning — that incomplete treatment could lead to drug-resistant TB — spurred him on. Nako completed his six-month regimen, now feeling strong, but believes better counselling could have eased his journey. “When you first hear the diagnosis, you are scared. Someone needs to explain what lies ahead.”
Similarly, mother-of-two Lawal Hassana credits unwavering family support for her recovery, as they diligently reminded her to take her medication. Hassana, who experienced persistent chest pain and a cough for months before diagnosis, now educates her community: “I tell people not to hide their symptoms. TB is treatable if you act early.”
Nigeria's Staggering TB Burden: Key Facts
According to the World Health Organisation (WHO), Nigeria carries the heaviest TB burden in Africa and ranks sixth globally. The statistics paint a grim picture:
- Estimated Cases: 467,000 people living with active infections annually.
- Daily Deaths: Approximately 347 Nigerians die from TB every day.
- Hourly Deaths: Roughly 15 Nigerians perish from the disease every hour.
- Annual Fatalities: An estimated 125,000 deaths annually.
- Undetected Cases: About 175,000 TB cases remain undetected each year, fueling transmission (one untreated case can infect up to 15 others annually).
- Childhood TB: An estimated 61,000 children are affected annually.
The Federal Ministry of Health and Social Welfare, through the National Tuberculosis and Leprosy Control Programme (NTBLCP), offers free TB testing and treatment nationwide, striving to eradicate the epidemic by 2030. Yet, the burden remains severe.
The Peril of Incomplete Treatment and Delayed Diagnosis
Infectious disease specialist Dr. Ruth Adeniyi warns that incomplete medication is a major setback in Nigeria's TB control efforts. “TB treatment is not something you stop once you feel better. The moment symptoms reduce, many patients assume they are cured and abandon their drugs. That is very dangerous,” she stressed.
Consequences of Incomplete Treatment:
- Drug Resistance: Bacteria survive and adapt, leading to drug-resistant tuberculosis, which is harder and more expensive to treat.
- Harsher Treatment: Drug-resistant TB requires longer treatment durations with more potent, often harsher, drugs and has lower recovery rates.
- Community Transmission: Patients who stop treatment prematurely can still spread the infection, making adherence a public health priority, not just a personal one.
Pulmonologist Dr. Adamu Gimba noted that many patients present at health facilities only after the disease has significantly progressed. “Most people assume a persistent cough is something minor. By the time they come to the hospital, they have already spent weeks or months treating themselves for other illnesses,” he said. He emphasized that a cough lasting more than two weeks should never be ignored, as early detection simplifies treatment and curbs spread.
Expert Calls for Expanded Access and Stronger Systems
Public health specialist Dr. Tunji Badmus acknowledges improved testing rates due to awareness campaigns but points to a large number of undiagnosed cases. He advocates for:
- Community Screening: Expanding mobile testing units and outreach programmes to bridge gaps in rural areas.
- Integrated Healthcare: Integrating TB services into primary healthcare to improve accessibility.
Dr. Adeniyi Ruth reiterated the critical need for sustained investment in diagnostic and treatment infrastructure.
WHO Urges Domestic Funding, FG Deploys Technology
The World Health Organisation's Country Representative, Pavel Ursu, has called for increased domestic funding and stronger case detection in Nigeria, cautioning that declining donor support could undermine progress. He highlighted that 71% of TB patients and their households in Nigeria face catastrophic costs, underscoring the need for local ownership and investment in TB response.
Meanwhile, the Federal Government is deploying technology and innovation to accelerate TB eradication. Dr. Charles Nzelu, Director of Public Health at the Federal Ministry of Health and Social Welfare, confirmed the approval of $54 million for the procurement of essential drugs, including those for TB and HIV, to prevent stock-outs.
As part of the National Strategic Plan (2021–2026), the ministry is rolling out over 1,000 diagnostic equipment units and strengthening electronic reporting systems to ensure real-time data flow from healthcare facilities to the national dashboard. “Technology is only as strong as the systems that support it,” Nzelu concluded, signaling a renewed commitment to a robust, data-driven fight against TB.